Name: Strategy of developing preferred supplier agreements with the world’s top BioPharmas
Uploaded: 2022-02-28T11:59:18.179431+00:00
Duration: 1291 s
Channel: Vox Markets
Description: Strategy of developing preferred supplier agreements with the world’s top BioPharmas

https://d3ev5earl6dvd0.cloudfront.net/public-media/videos/003/421/003421/video_H28KHpW.mp4#t=215

Vox Markets

Strategy of developing preferred supplier agreements with the world’s top BioPharmas

How the ImmunoINSIGHTS platform is typically used

The division's H1 performance & expected growth trajectory for the rest of the year

Possible M&A opportunities

Does the group need to consider strengthening its balance sheet?

Update on the EarlyCDT lung cancer test

Why is the yearend being changed from May to Aug?

Future newsflow

Typical contract values/duration

Size of orderbook

In this interview, Adam Hill, CEO of Oncimmune #ONC - a global immunodiagnostics firm with a leading position in autoimmune profiling - explains:

How the ImmunoINSIGHTS platform is typically used. Start
Strategy of developing preferred supplier agreements with the world’s top BioPharmas. 03:35
The division's H1 performance & expected growth trajectory for the rest of the year. 06:15
Possible M&A opportunities. 12:20
Does the group need to consider strengthening its balance sheet? 13:45
Update on the EarlyCDT lung cancer test. 14:40
Why is the yearend being changed from May to Aug? 16:50
Future newsflow. 18:25
Typical contract values/duration. 19:20
Size of orderbook 20:25

In this interview, Adam Hill, CEO of Oncimmune #ONC - a global immunodiagnostics firm with a leading position in autoimmune profiling - explains:How the ImmunoINSIGHTS platform is typically used. Start Strategy of developing preferred supplier agreements with the world’s top BioPharmas. 03:35 The division's H1 performance &amp; expected growth trajectory for the rest of the year. 06:15 Possible M&amp;A opportunities. 12:20 Does the group need to consider strengthening its balance sheet? 13:45 Update on the EarlyCDT lung cancer test. 14:40 Why is the yearend being changed from May to Aug? 16:50 Future newsflow. 18:25 Typical contract values/duration. 19:20 Size of orderbook 20:25

https://d3ev5earl6dvd0.cloudfront.net/public-media/videos/003/421/003421/video_H28KHpW.mp4